- ICH GCP
- EU-Register für klinische Studien
Neueste Versuche
EudraCT Number: 2017-004851-22 | Sponsor Protocol Number: B7451015 | Start Date: | |||||||||||
Sponsor Name: Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001, U.S.A. | |||||||||||||
Full Title: A phase 3 multi-center, long-term extension study investigating the efficacy and safety of Abrocitinib, with or without topical medications, administered to subjects aged 12 years and older with m... | |||||||||||||
Medical condition: Moderate to severe atopic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) CZ (Ongoing) HU (Trial now transitioned) PL (Ongoing) NL (Ongoing) BG (Ongoing) BE (Ongoing) LV (Ongoing) ES (Ongoing) SK (Completed) FR (Completed) AT (Completed) SE (Prematurely Ended) IT (Ongoing) FI (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004828-11 | Sponsor Protocol Number: RECHMPL18_0038_prom_7574 | Start Date: | ||||||
Sponsor Name: University Hospital of Montpellier | ||||||||
Full Title: Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III study | ||||||||
Medical condition: adult and adolescent patients with univentricular heart diseases and pulmonary arterial pressure | ||||||||
|
||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: FR (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003220-78 | Sponsor Protocol Number: I8B-MC-ITSA | Start Date: | |||||||||||
Sponsor Name: Eli Lilly and Company | |||||||||||||
Full Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus | |||||||||||||
Medical condition: Diabetes Mellitus, Type 1 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002442-45 | Sponsor Protocol Number: AXAFA-AFNET5 | Start Date: | ||||||||||||||||||||||||||
Sponsor Name: Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)] | ||||||||||||||||||||||||||||
Full Title: Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy. | ||||||||||||||||||||||||||||
Medical condition: Atrial fibrillation catheter ablation | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) BE (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) AT (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006907-35 | Sponsor Protocol Number: SP915 | Start Date: | |||||||||||
Sponsor Name: Schwarz Biosciences GmbH | |||||||||||||
Full Title: Long-term extension of RECOVER A MULTICENTER, MULTINATIONAL, PHASE 3B, OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE LONG-TERM EFFECT OF THE 24-HOUR TRANSDERMAL DELIVERY OF ROTIGOTINE ON MOTOR FUNCTI... | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FI (Completed) ES (Completed) HU (Completed) IT (Completed) GB (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005641-19 | Sponsor Protocol Number: ENG K001 GF / EC 406 | Start Date: | |||||||||||
Sponsor Name: Takeda Pharma GmbH | |||||||||||||
Full Title: 3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients with Ut... | |||||||||||||
Medical condition: Uterine fibroids (Uterus myomatosus) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003676-39 | Sponsor Protocol Number: 109147 | Start Date: | ||||||
Sponsor Name: | ||||||||
Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) | ||||||||
Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri... | ||||||||
|
||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||
Trial protocol: NL (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006912-31 | Sponsor Protocol Number: AMV-12_12_2006 | Start Date: | ||||||
Sponsor Name: Universitätsklinikum Schleswig-Holstein | ||||||||
Full Title: Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial) | ||||||||
Medical condition: Respiratory distress syndrom of preterm infants (ICD 10: P22.0) | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||
Trial protocol: DE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000412-30 | Sponsor Protocol Number: LF111/401 | Start Date: | |||||||||||
Sponsor Name: Chemo Research S.L. | |||||||||||||
Full Title: A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with... | |||||||||||||
Medical condition: Oral contraception | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000205-77 | Sponsor Protocol Number: KF5503-75 | Start Date: | |||||||||||
Sponsor Name: Grünenthal GmbH | |||||||||||||
Full Title: Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged... | |||||||||||||
Medical condition: Moderate to severe acute pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |